Article Contents ::
- 1 The Brand Name LAB Has Generic Salt :: Labetalol
- 2 LAB Is From Company AKUMENTIS HC. Priced :: Rs. 119
- 3 LAB have Labetalol is comes under Sub class Miscellaneous of Main Class Anti Infectives
- 4 Main Medicine Class:: Anti Infectives Sub Medicine Class :: Miscellaneous
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name LAB Has Generic Salt :: Labetalol
LAB Is From Company AKUMENTIS HC. Priced :: Rs. 119
LAB have Labetalol is comes under Sub class Miscellaneous of Main Class Anti Infectives
Main Medicine Class:: Anti Infectives Sub Medicine Class :: Miscellaneous
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| Labetalol | TAB | Rs. 119 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| LAB | AKUMENTIS HC. | 100MG | 10 | Rs. 119 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From AKUMENTIS HC. :: LAB | Labetalol | Anti Infectives | Miscellaneous |
Indications for Drugs ::
Hypertension, Hypotensive anaesthesia
Drug Dose ::
Adult: PO HTN Initial: 100 mg twice daily, up to 200-400 mg twice daily. Max: 2.4 g/day in 2-4 divided doses. IV Emergency treatment of HTN 50 mg, repeat at 5-min intervals if needed, up to a total dose of 200 mg. HTN in pregnancy Initial: 20 mg/hr, double dose every 30 mins until a favourable response or a dose of 160 mg/hr is reached. HTN after MI Initial: 15 mg/hr, may increase slowly until a favourable response or a dose of 120 mg/hr is achieved. Hypotensive anesth Initial: 10-20 mg, may increase slowly if satisfactory hypotension is not reached after 5 mins.
Contraindication ::
2nd and 3rd degree heart block, cardiogenic shock, obstructive airway disease e.g. bronchial asthma, uncompensated heart failure, severe bradycardia, sick sinus syndrome, Prinzmetal’s angina, severe peripheral arterial disease.
Drug Precautions ::
Phaeochromocytoma, compensated heart failure, nonallergic bronchospasm. Avoid abrupt withdrawal. DM. Hepatic impairment. Perform LFTs. Elderly. Pregnancy and lactation.
Drug Side Effects ::
Orthostatic hypotension, dizziness, fatigue, vertigo, paraesthesia, headache, nasal stuffiness, dyspnoea, diarrhoea, abdominal pain, sexual dysfunction, dyspepsia, nausea, vomiting, scalp tingling, rash, increased transaminases, nightmares, worsening of intermittent claudication. Potentially Fatal: Hepatic injury.
Pregnancy category ::
3
Drug Mode of Action ::
Labetalol competitively inhibits the adrenergic stimulation of ?-receptors w/in the myocardium, bronchial and vascular smooth muscle, and ?1-receptors w/in vascular smooth muscle. It also has some intrinsic ?2-agonist and membrane-stabilising activity.
Drug Interactions ::
Synergistic hypotensive effect w/ halothane. Increased absolute bioavailability w/ cimetidine. Decreased absolute bioavailability w/ glutethimide. Additive hypotensive effect w/ nitroglycerin. Increased incidence of tremor w/ TCAs. Increased risk of bradycardia and heart block w/ Ca channel blocker (e.g. verapamil, diltiazem).
